An introduction to pharmacogenomics and why it should be considered in routine clinical practice. Additional discussion will be centred around some of the exciting new challenges in implementing pharmacogenomics in clinical practice.
Learning objectives:
- Define pharmacogenomics and relevant terminology
- Differentiate between testing and screening in pharmacogenomics
- Explain the impact of the liver and its enzymes on pharmacogenomics
- Outline pharmacogenomic applications in clinical pharmacy practice
- Describe the challenges in pharmacogenomics and its clinical implementation
This webinar is part of a three-part heart failure focussed cardiology webinar series. This webinar will cover the following learning objectives:
- Explain the barriers and enablers of implementing evidence-based heart failure management in practice
- Describe the practical considerations for the management of heart failure patients with other comorbidities, including diabetes
- Outline considerations for determining the optimal setting for medication initiation in heart failure patients (i.e., hospital vs. outpatients/primary care settings)